Aurobindo Pharma Soars: DGFT's Pen-G MIP Decision Boosts Shares
Market
C
CNBC TV18•30-01-2026, 09:27
Aurobindo Pharma Soars: DGFT's Pen-G MIP Decision Boosts Shares
- •Aurobindo Pharma shares surged over 5% after DGFT imposed Minimum Import Price (MIP) on Pen-G, 6-APA, and Amoxicillin.
- •MIPs are set for Pen-G (₹2,216/kg), Amoxicillin (₹2,733/kg), and 6-APA (₹3,405/kg), effective immediately until January 2027.
- •Aurobindo Pharma is India's sole company with a Pen-G plant, benefiting from the PLI scheme and a ₹2,700 crore investment.
- •The company's Pen-G plant has a 15,000-tonne capacity, exceeding India's annual need of 9,000 tonnes.
- •Analysts project a potential upside of ₹600-700 crore to Aurobindo Pharma's FY27 EBITDA due to this decision.
Why It Matters: DGFT's MIP on Pen-G and related drugs significantly benefits Aurobindo Pharma, boosting its market position and earnings.
✦
More like this
Loading more articles...
